1. Home
  2. SBFM vs BHFAN Comparison

SBFM vs BHFAN Comparison

Compare SBFM & BHFAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sunshine Biopharma Inc.

SBFM

Sunshine Biopharma Inc.

HOLD

Current Price

$1.35

Market Cap

7.2M

Sector

Health Care

ML Signal

HOLD

Logo Brighthouse Financial Inc. Depositary shares each representing a 1/1000th interest in a share of 5.375% Non-Cumulative Preferred Stock Series C

BHFAN

Brighthouse Financial Inc. Depositary shares each representing a 1/1000th interest in a share of 5.375% Non-Cumulative Preferred Stock Series C

HOLD

Current Price

$12.69

Market Cap

0.0

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
SBFM
BHFAN
Founded
2006
N/A
Country
United States
United States
Employees
N/A
1400
Industry
Biotechnology: Pharmaceutical Preparations
Life Insurance
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
7.2M
N/A
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
SBFM
BHFAN
Price
$1.35
$12.69
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$7.00
N/A
AVG Volume (30 Days)
41.0K
N/A
Earning Date
11-13-2025
N/A
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$37,323,742.00
N/A
Revenue This Year
$10.26
N/A
Revenue Next Year
$32.63
N/A
P/E Ratio
N/A
N/A
Revenue Growth
13.24
N/A
52 Week Low
$1.17
N/A
52 Week High
$3.90
N/A

Technical Indicators

Market Signals
Indicator
SBFM
BHFAN
Relative Strength Index (RSI) 36.12 42.87
Support Level $1.35 $12.48
Resistance Level $1.40 $12.80
Average True Range (ATR) 0.06 0.27
MACD 0.00 -0.02
Stochastic Oscillator 6.00 25.40

Price Performance

Historical Comparison
SBFM
BHFAN

About SBFM Sunshine Biopharma Inc.

Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. Through its subsidiaries, the company has various generic prescription drugs on the market in Canada and is also involved in developing and selling OTC supplements. In addition, the company is conducting a proprietary drug development program, which is comprised of K1.1 mRNA targeted for liver cancer and SBFM-PL4, PLpro protease inhibitor for SARS Coronavirus infections.

About BHFAN Brighthouse Financial Inc. Depositary shares each representing a 1/1000th interest in a share of 5.375% Non-Cumulative Preferred Stock Series C

Brighthouse Financial Inc is a United States-based provider of annuity products and life insurance through independent distribution channels and marketing arrangements with distribution partners. Its segments are Annuities, Life, Run-off and Corporate and Other. It derives a majority of the revenue from the Annuities segment which includes variable, fixed, index-linked, and income annuities. The life segment includes variable, term, universal, and whole life policies.

Share on Social Networks: